Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Beckman Daniella
Chief Financial Officer at Tango Therapeutics. Filing since 6 Feb 2024.
CIK 0001513422
Company
Date
Role
Action
Shares
Amount
Of holding
TNGX
Tango Therapeutics, Inc.
3 Feb 2026
Chief Financial Officer
Sold at will
10,317
$126.53K
5.3%
TNGX
Tango Therapeutics, Inc.
5 Feb 2025
Chief Financial Officer
Sold at will
3,948
$12.48K
2.6%
TNGX
Tango Therapeutics, Inc.
4 Feb 2025
Chief Financial Officer
Sold at will
4,284
$12.80K
2.7%
TNGX
Tango Therapeutics, Inc.
7 Feb 2024
Chief Financial Officer
Sold at will
1,817
$22.93K
1.4%
TNGX
Tango Therapeutics, Inc.
6 Feb 2024
Chief Financial Officer
Sold at will
1,908
$23.97K
1.4%
5 decisions on file.
